Involvement of purinergic P2 receptors in experimental retinal neovascularization

Current Eye Research

Volumn 33, Issue 3, 2008, Pages 285-291

  Sarman, Sylvia ^a   Mancini, Jorge ^b   Van Der Ploeg, Ingeborg ^a   Croxatto, J Oscar ^c   Kvanta, Anders ^a   Gallo, Juan E ^b  

^a ST ERIK S EYE HOSPITAL   (Sweden)

^b UNIVERSIDAD AUSTRAL   (Argentina)

^c Fundacion Oftalmologica Argentina Jorge Malbran   (Argentina)

Author keywords

Angiogenesis; Hypoxia; P2 receptors; Retina; ROP

Indexed keywords

DRUG DERIVATIVE; OXYGEN; PURINERGIC P2 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID; SURAMIN;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MOUSE; NEWBORN; PATHOLOGY; RETINA; RETINA NEOVASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; OXYGEN; PYRIDOXAL PHOSPHATE; RECEPTORS, PURINERGIC P2; RETINA; RETINAL NEOVASCULARIZATION; SURAMIN;

EID: 44049087407     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701885470     Document Type: Article

References (31)

1. Lazarowski E, Boucher R, Harden T. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol. 2003;64: 785-795.
2. P2 Receptors. Sigma-Aldrich.com/ehandbook. Rev 2002;8:64- 67.
3. P2 Receptors: P2Y G-Protein Family. Sigma-Aldrich.com/ehandbook. Rev 2002;8: 134-137.
4. Lambrecht G, Braun K, Damer S, Ganso M, Hildebrandt C, Ullman H, Kassack M, Nickel P. Structure-activity relationships of suramin, a pyridoxal-5- phosphate derivative as P2 receptor antagonists. Curr Pharmaceut Des. 2002;8: 2371-2399.
5. Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 1996;19: 13-18.
6. Sugioka M, Fukuda Y, Yamashita M. Ca2+ responses to ATP via purinoceptors in the early embryonic chick retina. J Physiol. 1996;493: 855-863.
7. Ianiev I, Uckermann O, Pannicke T, Wurm A, Tenckhoff S, Pietsch U, Reichenbach A, Wiedemann P, Bringmann A, Uhlmann S. Glial cell reactivity in a porcine model of retinal detachment. Invest Ophthalmol Vis Sci. 2006;47: 2161-2171.
8. Francke M,Weick M, Pannicke T, Uckermann O, Grosche J, Goczalik I, Milenkovic I, Uhlmann S, Faude F, Wiedemann P, Reichenbach A, Bringmann A. Up-regulation of extracellular ATP-inducedMüller cell responses in a dispase model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 2002;43: 870-881.
9. Sugiyama T, Kabayashi M, Kawamura H, Li Q, Puro D. Enhancement of P2X7-induced pore formation and apoptosis: An early effect of diabetes on the retinal microvasculature. Invest Ophthalmol Vis Sci. 2004;45: 1026-1032.
10. Sugiyama T, Oku H, Komori A, Ikeda T. Effect of P2X7 receptor activation on the retinal blood velocity of diabetic rabbits. Arch Ophthalmol. 2006;124: 1143-1149.
11. Sugiyama T, Kawamura H, Yamanishi S, Kobayashi M, Katsumura K, Puro D. Regulation of P2X7-induced pore formation and cell death in pericyte-containing retinal microvessels. Am J Physiol Cell Physiol. 2005;288:C568-C576.
12. Francke H, Klimke K, Brinckmann U, Grosche J, Francke M, Sperlagh B, Reichenbach A, Liebert UG, Illes P. P2X(7) receptor-mRNA and protein in the mouse retina; changes during retinal degeneration in BALBCrds mice. Neurochem Int. 2005;47: 235-242.
13. Bucolo C, Marrazzo A, Ronsisvalle S, Ronsisvalle G, Cuzzocrea S, Mazzon E, Caputi A, Drago F. A novel adamantane derivative attenuates retinal ischemic-reperfusion damage in the rat retina through σ1 receptors. Eur J Pharmacol. 2006;536: 200-203.
14. Osborne N, Schwarz M, Pergande G. Protection of rabbit retina from ischemic injury by flupirtine. Invest Ophthalmol. Vis Sci. 1996;37: 274-280.
15. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg. 1992;77: 169-184.
16. Morigiwa K, Quan M, Murakami M, Yamashita M, Fukuda Y. P2 purinoceptor expression and functional changes of hypoxia-activated cultured rat retinal microglia. Neurosci Lett. 2002;282: 153-156.
17. Fruttiger M. Development of the mouse retinal vasculature: Angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci. 2002;43: 522-527.
18. Yancopoulos GD, Davis S, Gale NW, Rudge JS,Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407: 249-257.
19. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407: 249-257.
20. Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9: 653-660.
21. Smith L,Wesolowski E, McLellan A, Kostyk S, D'Amato R, Sullivan R, D'Amore P. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35: 101-111.
22. Eichhorst S, Krueger A, Müerköster S, Fas S, Golks A, Gruetzner U, Schubert L, Opelz C, Bilzer M, Gerbes A, Krammer P. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat Med. 2004;10: 602-609.
23. Honore P, Mikusa J, Bianchi B, McDonald H, Cartmell J, Faltynek C, Jarvis M. TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: Comparison with reference analgesics. Pain. 2002;96: 99-105.
24. Greenwood D, Yao W, Housley G. Expression of the P2X2 receptor subunit of the ATP-gated ion channel in the retina. Neuroreport. 1997;8: 1083-1088.
25. Kaneda M, Ishii K, Morishima Y, Akagi T, Yamazaki Y, Nakanishi S, Hashikawa T. OFF-cholinergic-pathway-selective localization of P2X2 purinoceptors in the mouse retina. J Comp Neurol. 2004;476: 103-111.
26. Puthussery T, Fletcher E. P2X2 receptors on ganglion and amacrine cells in cone pathways of the rat retina. J Comp Neurol. 2006;496: 595-609.
27. Fries J, Wheeler-Schilling T, Guenther E, Kohler K. Expression of P2Y1, P2Y2, P2Y4 and P2Y6 receptor subtypes in the rat retina. Invest Ophthalmol Vis Sci. 2004;45: 3410-3417.
28. Fries J, Wheeler-Schilling T, Kohler K, Guenther E. Distribution of metabotropic P2Y receptors in the rat retina: A single-cell RT-PCR study. Mol Brain Res. 2004;130: 1-6.
29. Cavaliere F, Florenzano F, Amadio S, Fusco F, Viscomi M, D'Ambrosi N, Vacca F, Sancesario G, Bernardi G, Molinari M, Volonte C. Up-regulation of P2X2, P2X4 receptor and ischemic cell death: Prevention by P2 antagonists. Neuroscience. 2003;120:85- 98.
30. Waltenberger J, Mayr U, Frank H, Hombach V. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J Mol Cell Cardiol. 1996;28: 1523-1529.
31. Kathir K, Kumar T, Yu C. Understanding the mechanism of the antimitogenic activity of suramin. Biochemistry. 2006;45: 899-906.